Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$42,432,000
+$3,260,000 QoQ
Shares Held
1,200,000
-14.3% QoQ
Ownership
0.720%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Avoro Capital Advisors LLC holds $1,601,969,400 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,630,000 | $1,559,537,400 | |
| 2 | ALKS |
Alkermes plc.
This page
|
1,200,000 | $42,432,000 |
All Filings in ALKS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,432,000 | 1,200,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $39,172,000 | 1,400,000 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $67,200,000 | 2,240,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $82,969,000 | 2,900,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $80,899,000 | 2,450,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $70,462,000 | 2,450,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||